Pisgah Labs Seeks DEA Nod to Import Drug Precursors
Published Date: 3/19/2026
Notice
Summary
Pisgah Laboratories Inc wants to become an official importer of certain controlled substances like Phenylacetone and Ecgonine. People and companies involved can share their thoughts or ask for a hearing by April 20, 2026. This move could impact drug manufacturing and import rules, but no direct costs are mentioned yet.
Analyzed Economic Effects
3 provisions identified: 2 benefits, 1 costs, 0 mixed.
Application to Import Schedule II Substances
Pisgah Laboratories Inc applied on January 23, 2026 to be registered as an importer for four Schedule II controlled substances: Phenylacetone (drug code 8501), Ecgonine (9180), Thebaine (9333), and Tapentadol (9780). The company plans to manufacture these substances in bulk for distribution to its customers, and no other activities for these drug codes are authorized under the application.
Import Authorization Excludes Finished Dosage Forms
The DEA notice states that any approval will not authorize the import of Food and Drug Administration-approved or non-approved finished dosage forms for commercial sale; authorization is limited to the listed bulk controlled substance activities consistent with 21 U.S.C. 952(a)(2).
Comment and Hearing Deadline for Stakeholders
Registered bulk manufacturers of the affected drug classes and other applicants may submit electronic comments or objections, or request a hearing, on or before April 20, 2026 via https://www.regulations.gov or by filing written hearing requests to DEA addresses provided in the notice.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-06523 — Designation of P2P Methyl Glycidic Acid as a List I Chemical
Starting May 4, 2026, anyone handling P2P methyl glycidic acid—a key chemical used to make illegal drugs like methamphetamine—must follow new government rules and register with the DEA. This means all transactions, big or small, will be closely watched to stop illegal drug production. Businesses dealing with this chemical should act fast to stay legal and avoid penalties.
2026-06521 — Importer of Controlled Substances Application: Lipomed/LGC Standards
Lipomed/LGC Standards wants to become an official importer of certain controlled substances, like 3-Fluoro-N-methylcathinone. This means companies involved with these drugs can comment or ask for a hearing by May 4, 2026. If approved, it could impact how these substances enter the U.S., but no direct costs are mentioned yet.
2026-06051 — Importer of Controlled Substances Application: Usona Institute
Usona Institute wants to become an official importer of some powerful controlled substances like mescaline and psilocybin. People who make or use these drugs can share their thoughts or ask for a hearing by April 29, 2026. This move could impact research and medical use, with no direct cost changes announced yet.
2026-05912 — Bulk Manufacturer of Controlled Substances Application: SpecGx LLC
SpecGx LLC wants to become a big-time maker of some powerful and tightly controlled drugs, including things like psilocybin and fentanyl. People and companies already registered can share their thoughts or ask for a hearing by May 26, 2026. This move could shake up how these substances are made and handled, so keep an eye on the deadlines if you’re involved!
2026-05618 — Schedules of Controlled Substances: Placement of 3-Methoxyphencyclidine (1-(1-(3-Methoxyphenyl)cyclohexyl)piperidine) in Schedule I
Starting April 22, 2026, the DEA is putting 3-methoxyphencyclidine (3-MeO-PCP) into Schedule I, meaning it’s now officially a highly controlled substance with strict rules. This affects anyone who makes, sells, studies, or even possesses 3-MeO-PCP, who will face serious legal consequences. This move helps the U.S. follow international drug laws and keeps communities safer.
2026-05486 — Exempt Chemical Preparations Under the Controlled Substances Act
The Drug Enforcement Administration (DEA) just updated which chemical mixes are officially exempt from strict drug rules between September 2024 and December 2025. Companies and labs using these chemicals should check the new list to see if their products are approved or denied. You’ve got until May 19, 2026, to share your thoughts, and no extra fees are involved—just a quick review and comment if you want!
Previous / Next Documents
Previous: 2026-05359 — Importer of Controlled Substances Application: United States Pharmacopeial Convention
The United States Pharmacopeial Convention wants to become an official importer of certain controlled substances like Cathinone and Methcathinone. If you’re a registered manufacturer or interested party, you have until April 20, 2026, to share your thoughts or ask for a hearing. This move could impact how these substances are imported and tracked, but no direct costs are mentioned.
Next: 2026-05361 — Health Systems Research Scientific Merit Review Board
The Department of Veterans Affairs is renewing its Health Systems Research Scientific Merit Review Board for two more years to keep picking the best research projects that help veterans. This board, made up of experts, advises on research priorities and ensures VA funds are used wisely, with a budget of about $1.45 million. Veterans, researchers, and taxpayers benefit from this smart, fair review process continuing through 2028.
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in